The Substance Abuse and Mental Health Services Administration (SAMHSA) is accepting applications for fiscal year (FY) 2020 COVID-19 Emergency Response for Suicide Prevention (Short Title: COVID-19 ERSP) grants. SAMHSA recognizes there are currently 57.8 million Americans living with mental and/or substance use disorders (National Survey on Drug Use and Health, 2018). Currently, suicide is the tenth leading cause of death in our nation.

This notice announces the opportunity to apply for funding under the Rural Communities Opioid Response Program – Planning (RCORP-Planning). RCORP is a multi-year HRSA initiative with the goal of reducing morbidity and mortality resulting from substance use disorder (SUD), including opioid use disorder (OUD), in high risk rural communities. This funding opportunity, RCORP-Planning, will advance RCORP’s overall goal by strengthening and expanding the capacity of rural communities to provide SUD/OUD prevention, treatment, and recovery services.

The Rheumatology Research Foundation is issuing a notice of special interest (NOSI) to highlight the availability of funds for projects exploring the relationships between rheumatic and musculoskeletal diseases and SARS-CoV-2, the virus that causes COVID-19.

The Foundation accepts submissions within the following scientific categories:
•Basic Science
•Translational Science
•Clinical Science
•Health Services Research
•Patient- or Practice-Centered Research

Recent clinical experience has shown that people with diabetes are at higher risk of death from COVID19 and that COVID-19 drives an increased risk of hyperglycemia and other complications in those with and without diabetes. This is in addition to the risk due to advanced age and chronic disease. Both the biological mechanisms underlying this risk and how to minimize it remain poorly understood. There is an urgent need for research to understand the impact of diabetes on COVID-19 and vice versa. This is true at a basic and clinical level. 
 

The Ferring COVID-19 Investigational Grants in Reproductive Medicine and Maternal Health (RMMH) are designed to provide funding to gather data related to IVF programmes during the COVID-19 pandemic including but not limited to:  

Follow-up data on infected pregnant patients at different gestational stages, including spontaneous pregnancies.  

This Funding Opportunity Announcement (FOA) invites R01 grant applications for funding to support novel, high-impact studies evaluating the responsiveness of healthcare delivery systems, healthcare professionals, and the overall U.S. healthcare system to the COVID-19 pandemic.